Alpha Tau Medical Ltd. - Ordinary Shares (NQ:DRTS)

14.48 -0.41 (-2.75%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alpha Tau Medical Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 17, 2023

Via Benzinga

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

August 17, 2023

From Alpha Tau Medical Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 25, 2023

Via Benzinga

Recap: Alpha Tau Medical Q1 Earnings ↗

May 23, 2023

Via Benzinga

Sidoti Events, LLC's Virtual June Small-Cap Conference

June 13, 2023

Via ACCESSWIRE

Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University

May 17, 2023

-First patient treated in the feasibility and safety study of intratumoral diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of new and recurrent squamous cell carcinoma of the...

From Alpha Tau Medical Ltd.

Via GlobeNewswire

Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open

May 11, 2023

From Alpha Tau Medical Ltd.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023 ↗

April 24, 2023

Via Benzinga

Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial

April 03, 2023

First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer.

From Alpha Tau Medical Ltd.

Via GlobeNewswire

Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial

March 08, 2023

From Alpha Tau Medical Ltd.

Via GlobeNewswire

Alpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases

March 01, 2023

From Alpha Tau Medical Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 12, 2023

Via Benzinga

Tesla To $176? Here Are 5 Other Price Target Changes For Wednesday ↗

November 23, 2022

Citigroup raised Tesla, Inc. (NASDAQ: TSLA) price target from $141.33 to $176. . Citigroup analyst Itay Michaeli upgraded the stock from Sell to Neutral. Tesla shares rose 1.2% to close at $169.91 on...

Via Benzinga

Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 12, 2023

Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity...

Via Benzinga

Alpha Tau to Present at Upcoming November Investor Conferences

November 09, 2022

From Alpha Tau Medical Ltd.

Via GlobeNewswire

Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗

November 28, 2022

Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share.

Via Benzinga

Why Quanergy Systems Shares Are Trading Sharply Lower; Here Are 28 Stocks Moving Premarket ↗

October 31, 2022

Gainers Selina Hospitality PLC (NASDAQ: SLNA) rose 31.9% to $19.90 in pre-market trading after dipping around 63% on Friday.

Via Benzinga

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗

October 31, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

Via Benzinga

Alpha Tau Announces Multiple Corporate Updates Ahead of 2022 Annual Meeting of the American Society for Radiation Oncology

October 21, 2022

From Alpha Tau Medical Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 26, 2022

Gainers Ontrak (NASDAQ:OTRKP) shares increased by 28.8% to $2.1 during Monday's pre-market session.

Via Benzinga

Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday ↗

September 26, 2022

Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.

Via Benzinga

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday ↗

September 19, 2022

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 16, 2022

Via Benzinga

Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session ↗

September 16, 2022

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.

Via Benzinga

Bowlero, Harmonic And Some Other Big Stocks Moving Higher On Friday ↗

September 16, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday ↗

August 19, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

Via Benzinga

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

August 18, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.